Insulin therapy in critically ill patients

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 1089-1101

  Ellahham, Samer ^a  

^a Samer Ellahham and Associates   (United States)

Author keywords

Cardiovascular disease; Critical care; Hyperglycemia; Insulin; Intensive care

Indexed keywords

GLICLAZIDE; GLUCOSE; INDAPAMIDE PLUS PERINDOPRIL; INSULIN; INSULIN GLARGINE; PLACEBO;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CRITICALLY ILL PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; REVIEW;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 80051876979     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S14203     Document Type: Review

References (99)

1. Cydulka RK,Maloney GE. Diabetes mellitus and disorders of glucose homeostasis. In: Rosen's Emergency Medicine. 7th ed. St Louis, MO: Mosby Elsevier; 2009;124:1633-1649.
2. National Diabetes Information Clearinghouse, a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. National Diabetes Statistics, 2007. Available from: http://diabetes.niddk.nih.gov/dm/pubs/statistics/. Accessed 2010 Sep 20.
3. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335-342.
4. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353-369.
5. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982.
6. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control: A call to action. Diabetes Care. 2006;29(8):1955-1962.
7. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2): 553-591.
8. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
9. Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(1):77-82.
10. Rhoads GG, Kosiborod M, Nesto RW, et al. Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine. Am J Cardiol. 2009;104(7):910-916.
11. Juhaeri J, Gao S, Dai WS. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin. Pharmacoepidemiol Drug Saf. 2009;18(6):497-503.
12. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.
13. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.
14. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-827.
15. American Diabetes Association. Standards of Medical Care in Diabetes - 2010. Diabetes Care. 2010;33 Suppl 1:S11-S61.
16. Shehadeh N, On A, Kessel I, et al. Stress hyperglycemia and the risk for the development of type 1 diabetes. J Pediatr Endocrinol Metab. 1997;10(3):283-286.
17. Weiss SL, Alexander J, Agus MS. Extreme stress hyperglycemia during acute illness in a pediatric emergency department. Pediatr Emerg Care. 2010;26(9):626-632.
18. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest. 2004;126(3):879-887.
19. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004;25(21):1880-1890.
20. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999;22(11): 1827-1831.
21. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471-1478.
22. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21(2): 246-249.
23. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet. 2002;359(9324): 2140-2144.
24. Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1C with cardiovascular disease and mortality in adults: The European Prospective Investigation into Cancer in Norfolk. Ann Intern Med. 2004;141(6):413-420.
25. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J. 1988;9(3):259-264.
26. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: The Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care. 2005;28(10):2551-2553.
27. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA. 2005;293(4):437-446.
28. Bolk J, van der Ploeg TJ, Cornel JH, Arnold AER, Sepers J, Umans VAWM. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79(2-3):207-214.
29. Furnary A P, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-1021.
30. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet. 2000;355(9206): 773-778.
31. Lemesle G, Bonello L, de Labriolle A, et al. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation. Am J Cardiol. 2009;104(1):41-45.
32. Aronson D, Hammerman H, Suleiman M, Markiewicz W. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. Am J Cardiol. 2009;104(8):1013-1017.
33. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: Impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006;27(22):2716-2724.
34. Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57-65.
35. Malmberg K; for the DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314(7093):1512-1515.
36. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J. 2005;26(7):650-661.
37. Magee MF. Insulin therapy for intensive glycemic control in hospital patients. Hosp Physician. 2006;38:17-28.
38. Furnary A P, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: The Portland Diabetic Project. Endocr Pract. 2006; 12 Suppl 3:22-26.
39. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559.
40. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2):129-139.
41. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572.
42. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials: A position statement of the American Diabetes Association and a Scientifc Statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009;119(2):351-357.
43. Kerr M. Intensive glycemic control not directly linked to excess cardiovascular risk. Heartwire. 2009 Jun 10. Available from: http://www.theheart.org/article/978067.do. Accessed 2010 Sep 20.
44. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA1c in people with type 2 diabetes: A retrospective cohort study. Lancet. 2010;375(9713):481-489.
45. Balkau B, Simon D. Survival in people with type 2 diabetes as a function of HbA1c. Lancet. 2010;375(9713):438-440.
46. US National Institutes of Health. ClinicalTrials.gov Web site. The ORIGIN Trial (outcome reduction with initial glargine intervention). Available from: http://clinicaltrials.gov/ct2/results?term=NCT00069784. Accessed 2010 Sep 20.
47. US National Institutes of Health. ClinicalTrials.gov Web site. Impact of tight glycaemic control in acute myocardial infarction. Available from: http:// clinicaltrials.gov/ct2/results?term=NCT00237471. Accessed 2010 Sep 20.
48. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Intensive Care Med. 2009;35(10):1738-1748.
49. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2): 125-139.
50. Lipshutz AK, Gropper MA. Perioperative glycemic control: An evidence-based review. Anesthesiology. 2009;110(2):408-421.
51. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin therapy in critically ill patients: Predisposing factors and association with mortality. Crit Care Med. 2009;37(9):2536-2544.
52. Yu WK, Li WQ, Wang XD, et al. [Infuence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis]. Zhonghua Wai Ke Za Zhi. 2005;43(1):29-32.
53. Henderson WR, Dhingra VK, Chittock DR, et al. Survival Using Glucose Algorithm Regulation (SUGAR) Trial-Pilot Data. Presented at: the American Thoracic Society 2005 International Congress; 2005 May 22; San Diego, CA. Abstract A23.
54. Mitchell I, Knight E, Gissane J, et al. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Crit Care Resusc. 2006;8(4):289-293.
55. Wang LC, Lei S, Wu YC, et al. [Intensive insulin therapy in critically ill patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006;18(12): 748-750.
56. Azevedo JR, de Araujo LO, Azevedo RP. Intensive insulin therapy versus glycemic control in critically ill patients: a prospective controlled trial. Crit Care. 2007:11(suppl 3):S34.
57. McMullin J, Brozek J, McDonald E, et al. Lowering of glucose in critical care: a randomized pilot trial. J Crit Care. 2007;22(2):112-118.
58. Devos P, Preiser J, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GLUCONTROL study. Intensive Care Med. 2007;33:S189.
59. Iapichino G, Albicini M, Umbrello M, et al. Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients. Intensive Care Med. 2008;34(10):1843-1850.
60. He ZY, Li N, Xing J. Effect of intensive insulin therapy on short-term outcome in critically ill patients. Chinese J Clin Nutr. 2008;16: 220-222.
61. Zhang R, He W, Li T. Evaluation of optimal goal of glucose control in critically ill patients. Chinese J Clin Nutr. 2008;16:204-208.
62. De La Rosa Gdel C, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.
63. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190-3197.
64. Mackenzie IM, Ercole A, Ingle S. Glycaemic control and outcome in general intensive care: The east anglian GLYCOGENIC study. Br J Intensive Care. 2008;18:121-126.
65. Bland DK, Fankhanel Y, Langford E, et al. Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. Am J Crit Care. 2005;14(5):370-376.
66. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis. 2006;22(2-3):116-122.
67. Farah R, Samokhvalov A, Zviebel F, Makhoul N. Insulin therapy of hyperglycemia in intensive care. Isr Med Assoc J. 2007;9(3): 140-142.
68. Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose control after resuscitation from ventricular fbrillation. Intensive Care Med. 2007;33(12):2093-2100.
69. Bruno A, Kent TA, Coull BM, et al. Treatment of Hyperglycemia In Ischemic Stroke (THIS). A Randomized Pilot Trial. Stroke. 2008;39(2): 384-389.
70. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10(suppl 2):46-52.
71. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfni R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anes-thesiol. 2007;19(3):156-160.
72. He W, Zhang T Y, Zhou H, et al. [Impact of intensive insulin therapy on surgical critically ill patients]. Zhonghua Wai Ke Za Zhi. 2007;45(15):1052-1054.
73. Bilotta F, Caramia R, Cernak I, et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care. 2008;9(2):159-166.
74. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663):547-556.
75. Yang M, Guo Q, Zhang X, et al. Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. Int J Nurs Stud. 2009;46(6):753-758.
76. Quinn TJ, Dawson J, Walters MR. Sugar and stroke: Cerebrovascular disease and blood glucose control. Cardiovasc Ther. 2010 May 13. [Epub ahead of print].
77. Baird TA, Parsons M W, Phanh T, et al. Persistent poststroke hyperg-lycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34(9):2208-2214.
78. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper-glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426-2432.
79. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6(5):397-406.
80. Ali NA, O'Brien JM, Jr., Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8):2316-2321.
81. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiol. 2006;105(2):244-252.
82. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36(11): 3008-3013.
83. Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM, Jr., May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg. 2008;74(8):679-685.
84. Al-Dorzi HM, Tamim HM, Arabi YM. Glycaemic fuctuation predicts mortality in critically ill patients. Anaesth Intensive Care. 2010;38(4):695-702.
85. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
86. Bode B W, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(suppl 2):71-80.
87. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27(2):461-467.
88. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8): 992-1000.
89. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care. 2008;31(suppl 1):S12-S54.
90. Schultz MJ, Royakkers AA, Levi M, Moeniralam HS, Spronk PE. Intensive insulin therapy in intensive care: an example of the struggle to implement evidence-based medicine. PLoS Med. 2006;3(12):e456.
91. Goldberg PA, Sakharova O V, Barrett P W, et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004;18(6): 690-697.
92. Quinn JA, Snyder SL, Berghoff JL, Colombo CS, Jacobi J. A practical approach to hyperglycemia management in the intensive care unit: evaluation of an intensive insulin infusion protocol. Pharmacotherapy. 2006;26(10):1410-1420.
93. Buchs AE, Bloemers R, Shiloah E, et al. Feasibility and safety of multiple daily insulin injections in general medicine wards. Eur J Intern Med. 2009;20(4):435-439.
94. Blaha J, Kopecky P, Matias M, et al. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care. 2009;32(5):757-761.
95. Avanzini F, Marelli G, Donzelli W, et al. Hyperglycemia during acute coronary syndrome: a nurse-managed insulin infusion protocol for stricter and safer control. Eur J Cardiovasc Nurs. 2009;8(3):182-189.
96. Yeldandi RR, Lurie A, Baldwin D. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglyce-mia in inpatients after cardiovascular surgery. Diabetes Technol Ther. 2006;8(6):609-616.
97. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181-2186.
98. Cook CB, Seifert KM, Hull B P, et al. Inpatient to outpatient transfer of diabetes care: planing for an effective hospital discharge. Endocr Pract. 2009;15(3):263-269.
99. Lavernia F. Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient care. Medscape J Med. 2008;10:216-233.